075586725195
|
Set Home
|
Favorite
|
中文
Home
About Us
Our Company
Research team
Clinical trials
Clinical trials
Enrollment procedure
Treatment Options for Cancer
Case report
Case report
Research direction
CART treatment
EIE treatment
Cancer vaccines
Gene therapy
Neoantigen Immunotherapy
GBM treatment
Publication
News
Newest Technology
Partners
Domestic partners
Foreign partners
FAQ
Neoantigen problem
31 questions
Contact Us
Contact us
Feedback
Home
About Us
Research team
Clinical trials
Case report
Research direction
News
Partners
FAQ
Contact Us
中文版
Case report
Case report
Case report
Case report
Case report
Case10# The First Japanese CART Experience with 4SCART Therapy
- 4 cases of pediatric acute lymphoblastic leukemia with central nervous syst ...
case11# The world first successful lentiviral gene therapy treating CGD
A 2-month-old boy with X-CGD The history of disease: ...
case12# The first South America B-Acute Lymphoblastic Leukemia (B-ALL) boy came to China for CART therapy…
Cancer History: First recurrence date: 06/2019 ...
Case13# Long term remission in a 2-year-old patient with refractory/recurrent rhabdomyosarcoma
Cancer History: First diagnosis of cancer: 09/2013 Rhabdomyosarc ...
Previous
1
2
3
Next
ADD: 深圳市南山区粤兴二道6号虚拟大学园重点实验室平台二层 TEL: 075586725195 Email: gimi_trials@szgimi.org
Copyright © 2016 Shenzhen Genoimmune Medical Institute all rights reserved.
Case report 
